PATENT DUCTUS ARTERIOSUS

Background: Device closure of Patent ductus arteriosus (PDA) using AmplatzerDuct Occluder (ADO) is a well-known modality to treat PDA with limited complicationsObjectives: To assess the efficacy, safety and immediate complications of percutaneous deviceclosure of PDA using Amplatzer Duct Occluder. Study Design: Descriptive case series. Placeand Duration of Study: Paediatric Cardiology Department of Faisalabad Institute of Cardiology,Faisalabad from May, 2012 to July, 2017. Methods: All consecutive patients undergoingcardiac catheterization for device closure were included. Detailed Echocardiography was doneby dedicated pediatric cardiologist before the procedure. Successfulness of procedure andproblems were recorded. Results: Out of 74 patients two had unsuitable anatomy for deviceocclusion so were excluded while 72 patients underwent successful device closure. Completeocclusion was achieved in all cases (100%) without any residual leak. There was not a singlecase of device embolization, LPA obstruction or Coarctation of aorta while upper end of deviceprotruded in descending aorta in12 patients (8.45%) with no obstruction in descending aorta.Three patients lost lower limb arterial pulse (4.17%) and one patient had week pulse (1.39%)but pulses revived after injection heparin and streptokinase. Conclusion: Device closure ofPDA using Amplatzer Duct Occluder is a safe and effective therapeutic modality with minimalcomplications